37 results match your criteria: "Anderson Orthopedic Research Institute[Affiliation]"
JSES Rev Rep Tech
November 2024
Department of Orthopedic Surgery, Banner Health, University of Arizona College of Medicine-Phoenix, The Orthopedic and Sports Medicine Institute, Phoenix, AZ, USA.
Background: Functional internal rotation (fIR) can be limited after reverse shoulder arthroplasty (RSA) and can result in difficulties performing activities of daily living (ADLs). The goal of this narrative review is to summarize the growing body of research on optimizing fIR after RSA that may be useful to clinical practice.
Methods: A narrative review of recent literature on IR after RSA.
Arthroplast Today
June 2023
Anderson Orthopedic Research Institute, Inova Center for Joint Replacement, Alexandria, VA, USA.
[This corrects the article DOI: 10.1016/j.artd.
View Article and Find Full Text PDFJ Arthroplasty
April 2023
Department of Orthopedic Surgery, Rush University Medical Center, Chicago, Illinois.
Background: Ketamine is administered intraoperatively to treat pain associated with primary total hip (THA) and knee arthroplasty (TKA). The purpose of this study was to evaluate the efficacy and safety of ketamine in primary THA and TKA to support the combined clinical practice guidelines of the American Association of Hip and Knee Surgeons (AAHKS), American Academy of Orthopaedic Surgeons (AAOS), Hip Society, Knee Society, and the American Society of Regional Anesthesia and Pain Management (ASRA).
Methods: The MEDLINE, Embase, and Cochrane Central Register of Controlled Trials databases were searched for studies published prior to 2020 on ketamine in THA and TKA.
J Arthroplasty
October 2022
Department of Orthopedic Surgery, Rush University Medical Center, Chicago, IL.
Background: Periarticular injection (PAI) is administered intraoperatively to help reduce postoperative pain and opioid consumption after primary total joint arthroplasty (TJA). The purpose of this study was to evaluate the efficacy and safety of PAI in primary TJA to support the combined clinical practice guidelines of the American Association of Hip and Knee Surgeons, American Academy of Orthopaedic Surgeons, Hip Society, Knee Society, and American Society of Regional Anesthesia and Pain Medicine.
Methods: The MEDLINE, Embase, and Cochrane Central Register of Controlled Trials databases were searched for studies published prior to March 2020 on PAI in TJA.
J Arthroplasty
October 2022
Rush University Medical Center, Chicago, Illinois.
Background: Corticosteroids are commonly used intraoperatively to treat pain and reduce opioid consumption and nausea associated with primary total joint arthroplasty (TJA). The purpose of this study was to evaluate the efficacy and safety of corticosteroids in primary TJA to support the combined clinical practice guidelines of the American Association of Hip and Knee Surgeons, American Academy of Orthopaedic Surgeons, Hip Society, Knee Society, and the American Society of Regional Anesthesia and Pain Management.
Methods: The MEDLINE, Embase, and Cochrane Central Register of Controlled Trials databases were searched for studies published before February 2020 on corticosteroids in TJA.
J Arthroplasty
September 2022
Department of Orthopedic Surgery, Rush University Medical Center, Chicago, Illinois.
J Arthroplasty
September 2022
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
J Arthroplasty
September 2022
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
J Arthroplasty
September 2022
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
J Arthroplasty
September 2022
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
Arthroplast Today
February 2022
Anderson Orthopedic Research Institute, Inova Center for Joint Replacement, Alexandria, VA, USA.
Background: Ceramic-on-ceramic (COC) bearings in total hip arthroplasty (THA) have long been considered the coupling with the lowest overall wear. However, concerns about complications such as ceramic breakage and noise, combined with the improved performance of polyethylene, have limited its use in the United States. This postapproval follow-up reports long-term (10 years) results of Delta COC in THA patients primarily enrolled in an Investigational Device Exemption study.
View Article and Find Full Text PDFClin Orthop Relat Res
April 2021
W. G. Hamilton, Clinical Instructor, Anderson Orthopedic Research Institute, Alexandria, VA, USA.
J Arthroplasty
October 2020
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) have become widely used to manage perioperative pain following total joint arthroplasty (TJA). The purpose of our study is to evaluate the efficacy and safety of NSAIDs in support of the combined clinical practice guidelines of the American Association of Hip and Knee Surgeons, American Academy of Orthopaedic Surgeons, Hip Society, Knee Society, and American Society of Regional Anesthesia and Pain Management.
Methods: Databases including MEDLINE, EMBASE, and the Cochrane Central Registry of Controlled Trials were searched for studies published prior to November 2018 on NSAIDs in TJA.
JBJS Case Connect
February 2021
J. Vernon Luck Sr. Orthopaedic Research Center at the Orthopaedic Institute for Children, Los Angeles, California.
Case: This was a postmortem retrieval study to assess bone fixation in a hydroxyapatite-coated ACTIS stem and a beaded Pinnacle Sector cup retrieved from an 89-year-old man 15-months postoperatively. Previous radiographic examinations showed good implant fixation without any radiolucency. The sectioned cup and stem showed good fixation on visual, microradiographic, and histological examinations.
View Article and Find Full Text PDFJ Arthroplasty
October 2020
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
J Arthroplasty
October 2020
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
Background: Gabapentinoids are commonly used as an adjunct to traditional pain management strategies after total joint arthroplasty (TJA). The purpose of this study is to evaluate the efficacy and safety of gabapentinoids in primary TJA to support the combined clinical practice guidelines of the American Association of Hip and Knee Surgeons, American Academy of Orthopaedic Surgeons, Hip Society, Knee Society, and the American Society of Regional Anesthesia and Pain Management.
Methods: The MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials were searched for studies published prior to November 2018 on gabapentinoids in TJA.
J Arthroplasty
October 2020
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
J Arthroplasty
October 2020
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
J Arthroplasty
October 2020
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
J Arthroplasty
October 2020
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
Background: Opioids are frequently used to treat pain after total joint arthroplasty (TJA). The purpose of this study was to evaluate the efficacy and safety of opioids in primary TJA to support the combined clinical practice guidelines of the American Association of Hip and Knee Surgeons, American Academy of Orthopaedic Surgeons, Hip Society, Knee Society, and the American Society of Regional Anesthesia and Pain Management.
Methods: The MEDLINE, EMBASE, and Cochrane Central Register of controlled trials were searched for studies published before November 2018 on opioids in TJA.
J Arthroplasty
October 2020
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
Background: Oral and intravenous (IV) acetaminophen has become widely used perioperatively as part of a multi-modal pain management protocol for primary total joint arthroplasty (TJA). The purpose of our study is to evaluate the efficacy and safety of acetaminophen in support of the combined clinical practice guidelines of the American Association of Hip and Knee Surgeons, American Academy of Orthopaedic Surgeons, Hip Society, Knee Society, and American Society of Regional Anesthesia and Pain Management.
Methods: We searched MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials for studies published prior to September 2019 on acetaminophen in primary TJA.
J Arthroplasty
October 2020
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
J Arthroplasty
September 2010
Anderson Orthopedic Research Institute, Alexandria, Virginia 22307, USA.
For the past 17 years, we have favored treating patients with polyethylene wear and osteolysis by performing a liner exchange with retention of the old shell when possible. Using our institutional database, we identified 187 acetabular revisions in which we had retained the old shell. Among this group, we found 25 rerevisions.
View Article and Find Full Text PDFJ Arthroplasty
October 2010
Anderson Orthopedic Research Institute, Alexandria, Virginia.
We report on 5 cases that underwent revision for locking ring failure in the Duraloc product line (DePuy, Warsaw, Ind). All liner retrievals showed signs of posterior neck/liner impingement and superior edge loading or significant wear. In these cases, we believe superior head migration and neck/liner impingement due to cup anteversion contributed to these locking ring failures.
View Article and Find Full Text PDFJ Arthroplasty
August 2010
Anderson Orthopedic Research Institute, Alexandria, Virginia 22307, USA.
This study examined 445 consecutive minimally invasive unicompartmental knee arthroplasties (UKAs) from one institution to determine whether revision and reoperation rates would decrease as the number of cases performed increased, indicating the presence of a learning curve with this procedure. At a mean of 3.25 years, 26 knees required revision yielding an overall revision rate of 5.
View Article and Find Full Text PDF